9 Things to Know About Inositol for Perimenopause Mood and Metabolism
The anxiety that showed up in perimenopause felt nothing like the worry I'd known before — it was physical, buzzing, arriving out of nowhere at 3am. When inositol kept coming up in research threads and forums, I kept dismissing it as fringe. Sitting with the actual studies changed that view entirely, and it's one of the things I most wish had been on the radar sooner.
Learn more about Rose →Inositol Is a Naturally Occurring Compound Your Body Already Makes
Inositol is a carbocyclic sugar found in cell membranes throughout the body and is sometimes loosely classified as a B-vitamin, though technically it isn't one. It's produced endogenously and also obtained through food — particularly citrus fruits, beans, and whole grains. The supplement form simply delivers higher concentrations than diet alone can realistically provide, which matters when the goal is a therapeutic effect.
The Two Forms That Matter Most Are Myo-Inositol and D-Chiro-Inositol
Of the nine naturally occurring forms of inositol, myo-inositol (MI) and D-chiro-inositol (DCI) are the most studied and the most physiologically active. They work via different but complementary pathways — MI primarily supports insulin signalling and FSH receptor function, while DCI is involved in glycogen synthesis and androgen regulation. Most of the clinical research uses either MI alone or a combined MI:DCI ratio of 40:1, which reflects the ratio found naturally in human blood plasma.
It Improves Insulin Sensitivity Through a Distinct Mechanism
Inositol acts as a secondary messenger in the insulin signalling cascade, meaning it helps cells actually respond to insulin rather than ignore it. When this pathway is sluggish — which becomes more common as oestrogen declines in perimenopause — blood sugar regulation suffers, and fat storage, energy crashes, and cravings can all worsen. Multiple randomised controlled trials have shown myo-inositol improves fasting glucose and insulin resistance markers, particularly in women with metabolic vulnerability.
Falling Oestrogen in Perimenopause Directly Disrupts the Insulin Pathway Inositol Supports
Oestrogen plays an active role in maintaining insulin sensitivity, partly by upregulating the same inositol phosphoglycan messengers that inositol supplementation supports. As oestrogen becomes erratic and then lower during perimenopause, this signalling pathway weakens — which is why insulin resistance tends to emerge or worsen during this transition even in women who haven't changed their diet or activity levels. Supplementing inositol essentially provides downstream support for a system that's losing hormonal scaffolding.
There Is Real Evidence for Its Effect on Anxiety
Inositol is a precursor to phosphatidylinositol, a molecule involved in serotonin and GABA receptor signalling in the brain — two neurotransmitter systems closely linked to anxiety regulation. A double-blind crossover trial published in the American Journal of Psychiatry found inositol significantly reduced the frequency of panic attacks compared to placebo, with an effect size comparable to fluvoxamine but with fewer side effects. For the low-grade, often inexplicable anxiety that many perimenopausal women describe, this biological plausibility is worth taking seriously.
It May Help Stabilise Irregular Cycles in Perimenopause
Much of the inositol research on ovulatory function has been done in women with PCOS, where it consistently improves cycle regularity and ovulation rates — but the mechanism is relevant to perimenopause too. Inositol supports FSH receptor sensitivity, and as FSH levels rise and become erratic in perimenopause, improving receptor responsiveness may help smooth out some of the cycle irregularity. The evidence in perimenopausal women specifically is still thin, but the underlying physiology makes it a plausible area of benefit.
It Has a Strong Safety Profile With Very Few Side Effects
Inositol has been used in clinical trials at doses up to 18g per day without serious adverse effects, which is a meaningful reassurance for a supplement category that often lacks safety data. The most commonly reported side effects are mild and gastrointestinal — occasional nausea or loose stools — and these are typically dose-dependent and transient. It has no known interactions with most common medications, though women on lithium or diabetes medications should check with a prescriber before starting.
Typical Therapeutic Doses Are Much Higher Than Food Can Provide
Clinical studies use myo-inositol doses of 2g to 4g per day for metabolic and mood benefits, while dietary intake from food is generally under 1g per day even on a varied diet. This gap is why food sources alone aren't a substitute for supplementation when a therapeutic effect is the goal. The 40:1 MI:DCI combination format tends to appear in studies targeting insulin sensitivity specifically, with a common dose being 2g MI and 50mg DCI twice daily.
It's Not a Hormone — But It Works on Systems That Hormones Govern
Inositol doesn't raise or mimic oestrogen, progesterone, or any other hormone, which matters for women who are cautious about anything that might interfere with hormone-sensitive conditions. What it does instead is support the downstream signalling systems that hormones rely on — making cells more responsive, neurotransmitter pathways more functional, and metabolic processes more efficient. For women who aren't candidates for or don't want hormonal therapy, this makes inositol one of the more genuinely useful non-hormonal options backed by real mechanistic evidence.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.